Global Health News: Surprises, Strategies, and Setbacks
Current health news highlights several impactful events. Viking Therapeutics' weight-loss pill trials disappoint, resulting in a 41% stock drop. Indian ministers suggest tax exemptions on insurance premiums to stimulate the economy. China's Bio-Thera licenses arthritis drug rights to Germany's STADA. EliseAI raises $250M to expand in healthcare automation.
In recent health developments, Viking Therapeutics' weight-loss trial results fell short of expectations, causing a 41% drop in share prices. The pill helped patients lose 12.2% of their body weight on average, as opposed to the expected 15%.
An Indian panel has proposed exemptions on health and life insurance taxes to stimulate the economy, following Prime Minister Modi's GST cuts amidst trade tensions.
In other global health news, China's Bio-Thera Solutions has signed a deal granting Germany's STADA commercialization rights for its arthritis drug, highlighting a significant international collaboration.
(With inputs from agencies.)
Advertisement
ALSO READ
SuperGaming raises USD 15 mn in fresh funding at 5 times higher valuation
CORE Energy Systems Secures Mega Funding for Nuclear Advancements
Rural Health Roadshow Brings Vital Reforms and Funding to Heartland NZ
Government Boosts Battery Storage with Viability Gap Funding
Trump Administration Freezes $584M Funding for UCLA Amid Protests
Google News